Do inflammatory bowel disease patients have reduced IPMK and HDAC3 activity with increased H4K16 acetylation and matrix metalloproteinase levels?

We analyzed the available evidence and found that 12 studies or assertions support the idea that people with inflammatory bowel disease show changes in certain proteins and chemical marks in their intestinal tissue that match patterns seen in mice lacking the IPMK protein. No studies or assertions...